John-Michael Gamble, Ph.D.
Affiliations: | 2012 | Public Health Sciences | University of Alberta, Edmonton, Alberta, Canada |
Area:
Public Health, PharmacyGoogle:
"John-Michael Gamble"Parents
Sign in to add mentor| Dean T. Eurich | grad student | 2012 | University of Alberta | |
| (The Impact of Restrictive Drug Coverage Policies on Pharmacoepidemiologic Methods and Health Outcomes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alkabbani W, Shah BR, Zongo A, et al. (2023) Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes, Obesity & Metabolism. 25: 3490-3500 |
| Alkabbani W, Zongo A, Minhas-Sandhu JK, et al. (2022) Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. Diabetic Medicine : a Journal of the British Diabetic Association. e14858 |
| Alkabbani W, Zongo A, Minhas-Sandhu JK, et al. (2021) Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study. Canadian Journal of Diabetes |
| Alkabbani W, Zongo A, Minhas-Sandhu JK, et al. (2021) Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study. Bmj Open Diabetes Research & Care. 9 |
| Alkabbani W, Gamble JM, Eurich DT, et al. (2021) Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes & Metabolism. 101305 |
| Hall JJ, Eurich DT, Nagy D, et al. (2020) Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials. Journal of General Internal Medicine |
| Donnan JR, Johnston K, Chibrikov E, et al. (2019) Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment. Canadian Journal of Diabetes |
| Donnan JR, Grandy CA, Chibrikov E, et al. (2019) Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis. Bmj Open. 9: e022577 |
| Gamble JM, Chibrikov E, Midodzi WK, et al. (2018) Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink. Bmj Open. 8: e023830 |
| Grandy CA, Donnan JR, Peddle JT, et al. (2018) A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products. Journal of the American Medical Informatics Association : Jamia |